VanderLaan, Paul A.
Beth Israel Deaconess Medical Center,
United States
2025 Rank: 52483
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 1577 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 52483 | 50103 |
| Total Cites | 723 | 795 |
| H-index | 11 | 13 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 15 | 16 |
| Number of Single+First Authored Papers | 35 | 35 |
| Total Cites to Single+First Authored Papers | 139 | 147 |
| Number of Single+First+Last Authored Papers | 55 | 55 |
| Total Cites to Single+First+Last Authored Papers | 347 | 365 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 626 | 663 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.20 |
| Self-Citation Percentage |
9.06%
|
|
VanderLaan, Paul A.
Harvard Medical School,
United States
2023 Rank: 65270
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 2360 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 65270 | 66896 |
| Total Cites | 533 | 574 |
| H-index | 11 | 12 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 25 | 27 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 150 | 163 |
| Number of Single+First+Last Authored Papers | 44 | 44 |
| Total Cites to Single+First+Last Authored Papers | 188 | 206 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 484 | 509 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.13 |
| Self-Citation Percentage |
7.14%
|
|
VanderLaan, Paul A.
Beth Israel Deaconess Medical Center,
United States
2022 Rank: 71736
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 2739 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 71736 | 79389 |
| Total Cites | 471 | 507 |
| H-index | 12 | 12 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 16 | 16 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 140 | 144 |
| Number of Single+First+Last Authored Papers | 40 | 40 |
| Total Cites to Single+First+Last Authored Papers | 178 | 186 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 443 | 470 |
| Ratio of Total Citations to Distinct Citing Papers | 1.06 | 1.08 |
| Self-Citation Percentage |
7.10%
|
|
VanderLaan, Paul A.
Harvard Medical School,
United States
2020 Rank: 75727
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 2656 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 75727 | 77557 |
| Total Cites | 507 | 556 |
| H-index | 12 | 13 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 15 | 17 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 142 | 150 |
| Number of Single+First+Last Authored Papers | 36 | 36 |
| Total Cites to Single+First+Last Authored Papers | 190 | 205 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 472 | 500 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.11 |
| Self-Citation Percentage |
8.81%
|
|